By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sun Pharmaceutical Industries Ltd 

Acme Plaza
Andheri Kurla Road
Andheri (East)  Mumbai  400 059  India
Phone: 91-22-821-12-88 Fax: 91-22-821-20-10



Company News
Sun Pharma (SUNPHARMA.NS) & Samsung Biologics Announce Strategic Manufacturing Tie-Up For Tildrakizumab 7/5/2017 8:05:53 AM
Sun Pharma (SUNPHARMA.NS) Announces U.S. FDA Filing Acceptance Of Biologics License Application (BLA) For Tildrakizumab 5/24/2017 6:30:30 AM
Almirall And Sun Pharma (SUNPHARMA.NS) Announce Regulatory Filing Of Tildrakizumab In Europe 3/24/2017 8:57:53 AM
FDA Lifts Ban On Sun Pharma (SUNPHARMA.NS)'s Mohali Plant Exports 3/14/2017 6:53:05 AM
Sun Pharma (SUNPHARMA.NS) Announces Positive Topline Results Of Confirmatory Phase-3 Clinical Trial For Seciera For Treatment Of Dry Eye 1/4/2017 7:46:53 AM
Sun Pharma (SUNPHARMA.NS) to Acquire Cancer Product from Novartis AG (NVS) for $175 Million 12/22/2016 6:47:23 AM
Sun Pharma (SUNPHARMA.NS) & Moebius Medical Sign Exclusive Global Licensing Deal To Develop Novel Liposomal Non-Opioid Pain Product For Osteoarthritis 12/12/2016 6:50:48 AM
Taro (TARO) Taps Sun Pharma (SUNPHARMA.NS) CFO as New CEO 11/22/2016 7:49:10 AM
Sun Pharma (SUNPHARMA.NS) To Announce Late-Breaking Results For Investigational IL-23p19 Inhibitor, Tildrakizumab, Achieves Primary End Point In Both Phase-3 Studies In Patients With Moderate-To-Severe Plaque Psoriasis 10/3/2016 7:32:59 AM
Sun Pharma (SUNPHARMA.NS), Lupin (LUPN.BO) Recall Over 41,500 Drug Bottles In U.S. 9/29/2016 8:47:18 AM